THE SCHEDULE 13G

Company

Viridian Therapeutics, Inc.\DE

Filed

November 9, 2020

Accession Number

0000921895-20-002842

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →